| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MET | Common Stock | Options Exercise | $1.2M | +26.1K | +5.27% | $45.91 | 522K | Dec 13, 2024 | Direct | |
| transaction | MET | Common Stock | Sale | -$1.73M | -20.9K | -4.01% | $82.84 | 501K | Dec 13, 2024 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MET | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -26.1K | -100% | $0.00 | 0 | Dec 13, 2024 | Common Stock | 26.1K | $45.91 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on December 13, 2024, and related tax obligations and fees. |
| F2 | The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $82.82 to $82.95, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. |
| F3 | Includes 2,787 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options. |
| F4 | The options became exercisable in three substantially equal installments on February 24, 2016, February 24, 2017, and February 27, 2018. |